Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

481
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
481
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

216
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
216
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

255
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
255
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

343
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
343
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

477
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
477
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.6K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcatheter closure of an apical post-infarction ventricular septal rupture after delayed anterior myocardial infarction complicated by cardiogenic shock and ventricular tachycardia.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026
Same author

Prognostic significance of carotid intima-media thickness in patients with coronary slow flow: A systematic review and meta-analysis.

International journal of cardiology. Cardiovascular risk and prevention·2026
Same author

Enormous Lifetime Variations and Anomalous Nonlinear Dynamics of Interlayer Excitons in Reconstructed MoSe<sub>2</sub>/WSe<sub>2</sub> Heterostructures.

Nano letters·2026
Same author

Spontaneous Twirls and Structural Frustration in Moiré Materials.

Physical review letters·2026
Same author

A study of extended lipid profile in patients with acute coronary syndrome: Focus on Lipoprotein(a) and PCSK9.

International journal of cardiology. Cardiovascular risk and prevention·2025
Same author

Concomitant production of industrially important enzyme from a novel fungal culture <i>Lasiodiplodia theobromae</i> using low-cost agro-waste under solid-state fermentation.

Preparative biochemistry & biotechnology·2025

Related Experiment Video

Updated: Sep 28, 2025

Analysis of the Lipid Composition of Mycobacteria by Thin Layer Chromatography
07:42

Analysis of the Lipid Composition of Mycobacteria by Thin Layer Chromatography

Published on: April 16, 2021

8.4K

Mycobacterium W. - An unusual side effect.

Rakesh K Chawla1, Aditya K Chawla2, Gaurav Chaudhary1

  • 1Jaipur Golden Hospital, Delhi, India.

The Indian Journal of Tuberculosis
|April 5, 2022
PubMed
Summary

A 70-year-old male with COVID-19 developed unusual skin side effects after receiving Mycobacterium W. injections. The pustules and ulcerations at injection sites healed without scarring after conservative management.

Keywords:
Adverse site reactionCOVID-19IntradermalMycobacterium W

More Related Videos

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.0K
Identification of Mycobacterium Species by DNA Microarray Chip Method
06:27

Identification of Mycobacterium Species by DNA Microarray Chip Method

Published on: June 24, 2025

189

Related Experiment Videos

Last Updated: Sep 28, 2025

Analysis of the Lipid Composition of Mycobacteria by Thin Layer Chromatography
07:42

Analysis of the Lipid Composition of Mycobacteria by Thin Layer Chromatography

Published on: April 16, 2021

8.4K
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.0K
Identification of Mycobacterium Species by DNA Microarray Chip Method
06:27

Identification of Mycobacterium Species by DNA Microarray Chip Method

Published on: June 24, 2025

189

Area of Science:

  • Immunology
  • Infectious Diseases
  • Dermatology

Background:

  • The study reports on a 70-year-old male diagnosed with COVID-19.
  • The patient had pre-existing conditions including Type-II Diabetes and Coronary Artery Disease (Post PTCA).

Observation:

  • The patient received Mycobacterium W. injections as an immunomodulator for COVID-19 treatment.
  • Unusual side effects manifested as bright red pustules at nine injection sites, progressing to ulcerations.

Findings:

  • The side effects occurred approximately 7-8 days post-administration.
  • Conservative management with oral analgesics and local steroids led to healing without scar formation within 8-10 days.

Implications:

  • This case highlights a rare adverse reaction to Mycobacterium W. injections in COVID-19 patients.
  • Proper administration technique (intradermal vs. subcutaneous) may be crucial in preventing such side effects.